Developer docs
API playgroundTry for free, no card

Search company profiles

Dalgety

Full company profile

uuid002wnfg

Namestring
Dalgety
Legal namestring
Dalgety Limited
Websiteurl
dalgetyuk.co.uk
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Dalgety Limited is a UK-based licensed medical cannabis cultivator and manufacturer headquartered at East Midlands Airport in Castle Donington, Derbyshire. The company operates a single 30,000 square foot EU-GMP certified indoor hydroponic facility — self-described as the only UK facility licensed to cultivate, manufacture, and supply GMP-certified medical cannabis. Dalgety produces pharmaceutical-grade dried cannabis flower for prescription use by UK patients with conditions where conventional treatments have proven inadequate, supplying through B2B distribution partnerships with Curaleaf Laboratories and Grow Pharma.

The cultivation platform combines an AI-controlled environmental monitoring system that regulates lighting, irrigation, humidity, and temperature with a systematic pheno-hunting programme and slow-curing post-harvest process. This stack delivers batch-to-batch consistency within ±10% of stated cannabinoid label values and compliance with European and British Pharmacopoeia standards. Product offerings include the High Society phenotype collection (Oracle, Heritage, Alchemy), Marshmallow OG (Chem MOG expression), and additional cultivars in development. The company markets itself as a domestic UK alternative to imported cannabis-based medicinal products, citing reduced lead times, full traceability, and avoidance of per-shipment MHRA and Home Office import licensing burdens.

Dalgety's go-to-market is enterprise B2B field sales targeting UK healthcare professionals, specialist prescribers, and clinical institutions, supported by a Knowledge Hub of educational content, a Medical Cannabis Clinicians Society partnership for CPD-accredited prescriber training, and active conference participation. Revenue is generated from one-time wholesale sales of EU-GMP certified cannabis flower to clinics, pharmacies, and distribution partners; pricing is not publicly disclosed. The company shipped its first commercial product in March 2025 and announced an £8M expansion drive in June 2025 to add cultivation rooms and introduce extraction capabilities.

Short descriptiontext

Dalgety is a UK-licensed cultivator and manufacturer of pharmaceutical-grade medical cannabis, operating an EU-GMP certified, AI-controlled indoor hydroponic facility at East Midlands Airport and supplying UK prescribers through Curaleaf and Grow Pharma.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCastle Donington, United Kingdom
HQ citystring
Castle Donington
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis cultivation, pharmaceutical cannabis manufacturing, EU-GMP cannabis production, cannabis cultivation services, medical cannabis distribution
NAICS code1 code
  • Medicinal and Botanical Manufacturing325411
SIC code1 code
  • Medicinal Chemicals & Botanical Products2833
Product category
Pharmaceutical Cannabis Cultivation and Manufacturing
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Cannabis Cultivation and Supply
TypeOne Time License
Description

Dalgety cultivates, harvests, dries, cures, and supplies EU-GMP certified medical cannabis flower to the UK medical community through distribution partners. Revenue is generated from the sale of pharmaceutical-grade cannabis products to clinics, pharmacies, and patients via prescription pathways.

dalgetyuk.co.uk
Marketing channels9 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Operations, Personnel, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Dalgety operates the only UK facility licensed to cultivate, manufacture, and supply EU-GMP certified pharmaceutical-grade medical cannabis flower. The company runs a 30,000 square foot indoor hydroponic facility with AI-controlled environmental systems, producing dried cannabis flower with consistent THC, CBD, and cannabinoid profiles for prescription use by UK patients via clinics, pharmacies, and pharmaceutical distribution partners.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Consistent cannabinoid profiles within ±10% of stated label value
+1 more record
Product overview1 text field

Dalgety is a UK-based medical cannabis producer operating a single 30,000 square foot EU-GMP certified indoor hydroponic facility with AI-controlled cultivation systems. The company's product portfolio includes branded medical cannabis flower products such as Marshmallow OG (including Chem MOG phenotype), and the High Society Phenotype Collection (Oracle, Heritage, and Alchemy). Dalgety also offers related services including medically-certified cultivation, product development partnerships with pharmaceutical manufacturers, large-scale distribution through distribution partners, and regulatory compliance support. The company operates an end-to-end controlled process from cultivation through drying, curing, and product development, with distribution facilitated through partnerships with Curaleaf Labs for UK manufacturing and distribution to clinics.

Product and service6 records
1Medical Cannabis Flower Products
Categorycore product
Description

EU-GMP certified dried cannabis flower for medical use, produced in Dalgety's 30,000 square foot UK facility with AI-controlled cultivation systems ensuring consistent THC, CBD and other cannabinoid levels. Sold to UK clinics, pharmacies, and pharmaceutical distributors for use in prescription medicines.

2High Society Phenotype Collection
Categorycore product
Description

Medical cannabis phenotype collection including High Society: Oracle, High Society: Heritage, and High Society: Alchemy — distinct medical cultivars developed through systematic pheno-hunting for consistent medical use.

3Marshmallow OG
Categorycore product
Description

Medical cannabis cultivar with Chem Dog lineage, available in Chem MOG phenotype expression. Part of Dalgety's branded medical cannabis portfolio for prescription use.

4Medically-Certified Cultivation Services
Categoryservice
Description

Advanced cannabis cultivation services compliant with EU GMP standards, featuring AI-controlled indoor hydroponic systems across a 30,000 square foot purpose-built facility, offered to pharmaceutical partners requiring compliant cultivation capacity.

5Product Development Services
Categoryservice
Description

Partnership with pharmaceutical manufacturers to develop cannabis-based medicinal products addressing specific patient needs, from cultivation through to finished pharmaceutical forms.

6Medical Cannabis Distribution
Categoryservice
Description

Large-scale distribution of GMP-certified medical cannabis products through established distribution partners to clinics, pharmacies and patients.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Dalgety and Curaleaf formed a strategic domestic supply chain partnership for the UK medical cannabis market. Dalgety's EU-GMP certified cultivation and pharmaceutical-grade production feeds into Curaleaf Labs' UK manufacturing, testing, and batch release. Curaleaf distributes finished patient prescription packs through its network of clinics, wholesalers and pharmacies. This partnership creates end-to-end UK alignment with clear MHRA/Home Office visibility from seed to sealed pack.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Dalgety partners with Grow Pharma to supply UK-grown medical cannabis products to the pharmaceutical market. Prof. Mike Barnes (Chair of MCCS) and Grow Pharma CEO Pierre van Weperen welcomed Dalgety as a supplier of high-quality medical cannabis to the UK prescription market, noting the collaboration brings UK-grown medicines with industry-leading expertise to patients.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Curaleaf Laboratories formalised a partnership with MCCS enabling the society to leverage Curaleaf's resources to deliver CPD-accredited education and shape a central source of information for UK prescribers. MCCS also works to improve access to education on medical cannabis and the endocannabinoid system for doctors, medical students, and allied healthcare professionals. Dr. Rowan Thompson, Vice Chair of MCCS, has contributed educational content featured on Dalgety's platform.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1EMMAC Life Sciences (SOMAI Pharmaceuticals)
TypeRegional player
Description

European medical cannabis group with UK and EU cultivation and distribution operations. Comparable as a regional peer competing for European medical cannabis market share with GMP-certified production.

TypeBroad incumbent
Description

UK-based arm of Curaleaf Holdings operating manufacturing and distribution for medical cannabis across Europe. Directly comparable as Dalgety's distribution partner and as a competing integrated producer/distributor in the UK market.

TypeBroad incumbent
Description

Canadian-licensed producer with European medical cannabis distribution, including into the UK. Comparable as a competing imported CBPM supplier where Dalgety's domestic positioning is a deliberate differentiator.

TypeEmerging player
Description

UK-based cannabinoid therapeutics company in clinical-stage development. Comparable as a UK-focused emerging player in the medical cannabis value chain with overlapping end-patient focus.

TypeBroad incumbent
Description

Global cannabis company with medical cannabis operations across multiple jurisdictions including Europe. Comparable as a competing GMP-certified medical cannabis brand serving similar patient populations.

TypeDirect peer
Description

UK-licensed medical cannabis cultivator focused on pharmaceutical-grade cannabis for the UK prescription market. Directly comparable as a UK GMP-certified cannabis producer targeting the same prescriber and patient base as Dalgety.

TypeBroad incumbent
Description

UK pioneer of cannabinoid medicines (Sativex, Epidyolex) and the established broad incumbent in the UK/European medical cannabis space. Relevant as the category leader Dalgety is positioned against in cannabinoid-based prescriptions.

TypeDirect peer
Description

UK medical cannabis distributor and supplier serving clinics and pharmacies with CBPMs. Comparable as a channel counterpart that competes for and distributes competing UK and imported medical cannabis products.

TypeEmerging player
Description

Medical cannabis company with European operations supplying CBPMs into the UK and EU. Comparable as a smaller international player competing in the same medical cannabis prescription channel as Dalgety.

10Tilray Brands
TypeBroad incumbent
Description

Global medical and recreational cannabis producer with established UK/European medical cannabis operations. Comparable as a large-scale GMP-certified competitor supplying CBPMs into the same UK prescription channel.

Market position
Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Dalgety

Pharmaceutical Cannabis Cultivation and Manufacturingdalgetyuk.co.uk

Dalgety is a UK-licensed cultivator and manufacturer of pharmaceutical-grade medical cannabis, operating an EU-GMP certified, AI-controlled indoor hydroponic facility at East Midlands Airport and supplying UK prescribers through Curaleaf and Grow Pharma.

What Dalgety does

Dalgety Limited is a UK-based licensed medical cannabis cultivator and manufacturer headquartered at East Midlands Airport in Castle Donington, Derbyshire. The company operates a single 30,000 square foot EU-GMP certified indoor hydroponic facility — self-described as the only UK facility licensed to cultivate, manufacture, and supply GMP-certified medical cannabis. Dalgety produces pharmaceutical-grade dried cannabis flower for prescription use by UK patients with conditions where conventional treatments have proven inadequate, supplying through B2B distribution partnerships with Curaleaf Laboratories and Grow Pharma.

The cultivation platform combines an AI-controlled environmental monitoring system that regulates lighting, irrigation, humidity, and temperature with a systematic pheno-hunting programme and slow-curing post-harvest process. This stack delivers batch-to-batch consistency within ±10% of stated cannabinoid label values and compliance with European and British Pharmacopoeia standards. Product offerings include the High Society phenotype collection (Oracle, Heritage, Alchemy), Marshmallow OG (Chem MOG expression), and additional cultivars in development. The company markets itself as a domestic UK alternative to imported cannabis-based medicinal products, citing reduced lead times, full traceability, and avoidance of per-shipment MHRA and Home Office import licensing burdens.

Dalgety's go-to-market is enterprise B2B field sales targeting UK healthcare professionals, specialist prescribers, and clinical institutions, supported by a Knowledge Hub of educational content, a Medical Cannabis Clinicians Society partnership for CPD-accredited prescriber training, and active conference participation. Revenue is generated from one-time wholesale sales of EU-GMP certified cannabis flower to clinics, pharmacies, and distribution partners; pricing is not publicly disclosed. The company shipped its first commercial product in March 2025 and announced an £8M expansion drive in June 2025 to add cultivation rooms and introduce extraction capabilities.

Dalgety firmographics

Firmographics
Name
Dalgety
Legal name
Dalgety Limited
Website
https://dalgetyuk.co.uk
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
11–50 employees
Short description
Dalgety is a UK-licensed cultivator and manufacturer of pharmaceutical-grade medical cannabis, operating an EU-GMP certified, AI-controlled indoor hydroponic facility at East Midlands Airport and supplying UK prescribers through Curaleaf and Grow Pharma.
Ownership category
akta.pro rank

Where Dalgety is headquartered

Location

Headquarters

HQ city
Castle Donington
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Dalgety business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Operations, Personnel, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Medical Cannabis Cultivation and Supply: Dalgety cultivates, harvests, dries, cures, and supplies EU-GMP certified medical cannabis flower to the UK medical community through distribution partners. Revenue is generated from the sale of pharmaceutical-grade cannabis products to clinics, pharmacies, and patients via prescription pathways.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels9 records

Dalgety product offering

Product offering

Core offering

Dalgety operates the only UK facility licensed to cultivate, manufacture, and supply EU-GMP certified pharmaceutical-grade medical cannabis flower. The company runs a 30,000 square foot indoor hydroponic facility with AI-controlled environmental systems, producing dried cannabis flower with consistent THC, CBD, and cannabinoid profiles for prescription use by UK patients via clinics, pharmacies, and pharmaceutical distribution partners.

Product overview

Dalgety is a UK-based medical cannabis producer operating a single 30,000 square foot EU-GMP certified indoor hydroponic facility with AI-controlled cultivation systems. The company's product portfolio includes branded medical cannabis flower products such as Marshmallow OG (including Chem MOG phenotype), and the High Society Phenotype Collection (Oracle, Heritage, and Alchemy). Dalgety also offers related services including medically-certified cultivation, product development partnerships with pharmaceutical manufacturers, large-scale distribution through distribution partners, and regulatory compliance support. The company operates an end-to-end controlled process from cultivation through drying, curing, and product development, with distribution facilitated through partnerships with Curaleaf Labs for UK manufacturing and distribution to clinics.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Cannabis Flower Products EU-GMP certified dried cannabis flower for medical use, produced in Dalgety's 30,000 square foot UK facility with AI-controlled cultivation systems ensuring consistent THC, CBD and other cannabinoid levels. Sold to UK clinics, pharmacies, and pharmaceutical distributors for use in prescription medicines.
  • High Society Phenotype Collection Medical cannabis phenotype collection including High Society: Oracle, High Society: Heritage, and High Society: Alchemy — distinct medical cultivars developed through systematic pheno-hunting for consistent medical use.
  • Marshmallow OG Medical cannabis cultivar with Chem Dog lineage, available in Chem MOG phenotype expression. Part of Dalgety's branded medical cannabis portfolio for prescription use.
  • Medically-Certified Cultivation Services Advanced cannabis cultivation services compliant with EU GMP standards, featuring AI-controlled indoor hydroponic systems across a 30,000 square foot purpose-built facility, offered to pharmaceutical partners requiring compliant cultivation capacity.
  • Product Development Services Partnership with pharmaceutical manufacturers to develop cannabis-based medicinal products addressing specific patient needs, from cultivation through to finished pharmaceutical forms.
  • Medical Cannabis Distribution Large-scale distribution of GMP-certified medical cannabis products through established distribution partners to clinics, pharmacies and patients.

Quantifiable outcome

  • Consistent cannabinoid profiles within ±10% of stated label value
  • +1 more outcomes

Companies that use Dalgety

Customer profile

Named customers2 records

Segments3 records

Ideal customer profiles3 records

Dalgety technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Dalgety partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Curaleaf LaboratoriescoreChannel Partner/ Reseller/ DistributorDalgety and Curaleaf formed a strategic domestic supply chain partnership for the UK medical cannabis market. Dalgety's EU-GMP certified cultivation and pharmaceutical-grade production feeds into Curaleaf Labs' UK manufacturing, testing, and batch release. Curaleaf distributes finished patient prescription packs through its network of clinics, wholesalers and pharmacies. This partnership creates end-to-end UK alignment with clear MHRA/Home Office visibility from seed to sealed pack.
  • Grow PharmacoreChannel Partner/ Reseller/ DistributorDalgety partners with Grow Pharma to supply UK-grown medical cannabis products to the pharmaceutical market. Prof. Mike Barnes (Chair of MCCS) and Grow Pharma CEO Pierre van Weperen welcomed Dalgety as a supplier of high-quality medical cannabis to the UK prescription market, noting the collaboration brings UK-grown medicines with industry-leading expertise to patients.
  • Medical Cannabis Clinicians Society (MCCS)coreStrategic or Co-development PartnerCuraleaf Laboratories formalised a partnership with MCCS enabling the society to leverage Curaleaf's resources to deliver CPD-accredited education and shape a central source of information for UK prescribers. MCCS also works to improve access to education on medical cannabis and the endocannabinoid system for doctors, medical students, and allied healthcare professionals. Dr. Rowan Thompson, Vice Chair of MCCS, has contributed educational content featured on Dalgety's platform.

Scale indicators6 records

Recent moves7 records

Expansion highlights5 records

Dalgety competitors and assessment

Company assessment

Regional players

  • EMMAC Life Sciences (SOMAI Pharmaceuticals): European medical cannabis group with UK and EU cultivation and distribution operations. Comparable as a regional peer competing for European medical cannabis market share with GMP-certified production.

Broad incumbents

  • Curaleaf International: UK-based arm of Curaleaf Holdings operating manufacturing and distribution for medical cannabis across Europe. Directly comparable as Dalgety's distribution partner and as a competing integrated producer/distributor in the UK market.
  • Aurora Cannabis: Canadian-licensed producer with European medical cannabis distribution, including into the UK. Comparable as a competing imported CBPM supplier where Dalgety's domestic positioning is a deliberate differentiator.
  • Canopy Growth Corporation: Global cannabis company with medical cannabis operations across multiple jurisdictions including Europe. Comparable as a competing GMP-certified medical cannabis brand serving similar patient populations.
  • GW Pharmaceuticals (Jazz Pharmaceuticals): UK pioneer of cannabinoid medicines (Sativex, Epidyolex) and the established broad incumbent in the UK/European medical cannabis space. Relevant as the category leader Dalgety is positioned against in cannabinoid-based prescriptions.
  • Tilray Brands: Global medical and recreational cannabis producer with established UK/European medical cannabis operations. Comparable as a large-scale GMP-certified competitor supplying CBPMs into the same UK prescription channel.

Emerging players

  • Oxford Cannabinoid Technologies: UK-based cannabinoid therapeutics company in clinical-stage development. Comparable as a UK-focused emerging player in the medical cannabis value chain with overlapping end-patient focus.
  • Khiron Life Sciences: Medical cannabis company with European operations supplying CBPMs into the UK and EU. Comparable as a smaller international player competing in the same medical cannabis prescription channel as Dalgety.

Direct peers

  • Celadon Pharmaceuticals: UK-licensed medical cannabis cultivator focused on pharmaceutical-grade cannabis for the UK prescription market. Directly comparable as a UK GMP-certified cannabis producer targeting the same prescriber and patient base as Dalgety.
  • Grow Pharma: UK medical cannabis distributor and supplier serving clinics and pharmacies with CBPMs. Comparable as a channel counterpart that competes for and distributes competing UK and imported medical cannabis products.

Market position

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Dalgety social profiles

Digital presence

Dalgety compliance and trust

Trust signal

Compliance3 records

Dalgety financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Dalgety leadership team

Management profile

Number of profiles

Profiles10 records

Dalgety funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Dalgety M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dalgety

What does Dalgety do?

Dalgety operates the only UK facility licensed to cultivate, manufacture, and supply EU-GMP certified pharmaceutical-grade medical cannabis flower. The company runs a 30,000 square foot indoor hydroponic facility with AI-controlled environmental systems, producing dried cannabis flower with consistent THC, CBD, and cannabinoid profiles for prescription use by UK patients via clinics, pharmacies, and pharmaceutical distribution partners.

Is Dalgety a public or private company?

Dalgety is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Dalgety founded?

Dalgety was founded in 2016. It employs 11 to 50 people.

Where is Dalgety based?

Dalgety is headquartered in Castle Donington, United Kingdom, in the Europe region.

How does Dalgety make money?

One revenue line is on record: medical Cannabis Cultivation and Supply.

Who are Dalgety's main competitors?

EMMAC Life Sciences (SOMAI Pharmaceuticals) is listed as a regional player. Broad incumbents are Curaleaf International, Aurora Cannabis, Canopy Growth Corporation, GW Pharmaceuticals (Jazz Pharmaceuticals) and Tilray Brands. Emerging players are Oxford Cannabinoid Technologies and Khiron Life Sciences. Direct peers are Celadon Pharmaceuticals and Grow Pharma.

Does Dalgety have an API?

No public API is recorded for Dalgety.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals